Asthma phenotypes: the evolution from clinical to molecular approaches, Nat Med, vol.18, pp.716-725, 2012. ,
National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program, Am J Respir Crit Care Med, vol.181, pp.315-323, 2010. ,
Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes, J Allergy Clin Immunol, vol.133, pp.1474-1477, 2014. ,
Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes, J Allergy Clin Immunol, vol.133, pp.997-1007, 2014. ,
Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data, J Allergy Clin Immunol, vol.133, pp.1280-1288, 2014. ,
Redefining approaches to asthma: developing targeted biologic therapies, Adv Pharmacol, vol.66, pp.1-49, 2013. ,
T-helper type 2-driven inflammation defines major subphenotypes of asthma, Am J Respir Crit Care Med, vol.180, pp.388-395, 2009. ,
Lebrikizumab treatment in adults with asthma, N Engl J Med, vol.365, pp.1088-1098, 2011. ,
Mepolizumab and exacerbations of refractory eosinophilic asthma, N Engl J Med, vol.360, pp.973-984, 2009. ,
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis, J Allergy Clin Immunol, vol.133, pp.921-923, 2014. ,
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia, Eur Respir J, vol.44, pp.239-241, 2014. ,
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia, N Engl J Med, vol.360, pp.985-993, 2009. ,
Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial, J Allergy Clin Immunol, vol.133, pp.989-996, 2014. ,
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma, J Allergy Clin Immunol, vol.123, pp.1185-1187, 2009. ,
IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?, Respir Res, vol.7, p.135, 2006. ,
Evidence for a cross-talk between human neutrophils and Th17 cells, Blood, vol.115, pp.335-343, 2010. ,
IL-17-producing T cells in lung immunity and inflammation, J Allergy Clin Immunol, vol.123, pp.995-996, 2009. ,
Innate lymphoid cells and asthma, J Allergy Clin Immunol, vol.133, pp.943-950, 2014. ,
Type 2 innate lymphoid cells: new players in asthma and allergy, Curr Opin Immunol, vol.24, pp.707-712, 2012. ,
Innate lymphoid cells-how did we miss them?, Nat Rev Immunol, vol.13, pp.75-87, 2013. ,
IL-33-responsive lineage-CD251 CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs, J Immunol, vol.188, pp.1503-1513, 2012. ,
Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation, Immunity, vol.40, pp.425-435, 2014. ,
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity, J Allergy Clin Immunol, vol.129, pp.216-227, 2012. ,
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity, Nat Med, vol.20, pp.54-61, 2014. ,
IL-17A and IL-17F expression in B lymphocytes, Int Arch Allergy Immunol, vol.157, pp.406-416, 2012. ,
Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgt and dectin-2, Nat Immunol, vol.15, pp.143-151, 2014. ,
Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing gdT cells, Am J Respir Crit Care Med, vol.182, pp.464-476, 2010. ,
Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17, J Exp Med, vol.205, pp.385-393, 2008. ,
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics, Am J Respir Crit Care Med, vol.160, pp.1001-1008, 1999. ,
National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis, J Allergy Clin Immunol, vol.133, pp.1557-1563, 2014. ,
Bleecker ER; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes, J Allergy Clin Immunol, vol.125, pp.1028-1036, 2010. ,
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines, J Allergy Clin Immunol, vol.108, pp.430-438, 2001. ,
Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine, Respir Med, vol.97, pp.726-733, 2003. ,
Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma, Chin Med J (Engl), vol.118, pp.953-956, 2005. ,
Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD, Chest, vol.138, pp.1140-1147, 2010. ,
Increased serum IL-17 is an independent risk factor for severe asthma, Respir Med, vol.104, pp.1131-1137, 2010. ,
Th17 immunity in patients with allergic asthma, Int Arch Allergy Immunol, vol.151, pp.297-307, 2010. ,
A novel subset of CD4(1) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma, J Exp Med, vol.207, pp.2479-2491, 2010. ,
Identification of a novel subset of human circulating memory CD4(1) T cells that produce both IL-17A and IL-4, J Allergy Clin Immunol, vol.125, pp.222-230, 2010. ,
Increased IL-17A secreting CD41 T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity, Clin Exp Allergy, vol.43, pp.1018-1026, 2013. ,
Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes, J Immunol, vol.180, pp.7423-7430, 2008. ,
Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma, J Allergy Clin Immunol, 2014. ,
Diesel exhaust particle induction of IL-17A contributes to severe asthma, J Allergy Clin Immunol, vol.132, pp.1194-1204, 2013. ,
Brodalumab, an antiinterleukin-17-receptor antibody for psoriasis, N Engl J Med, vol.366, pp.1181-1189, 2012. ,
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis, J Allergy Clin Immunol, vol.130, pp.145-154, 2012. ,
Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness, Am J Respir Crit Care Med, vol.180, pp.720-730, 2009. ,
Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge, Proc Natl Acad Sci, vol.104, pp.15817-15822, 2007. ,
Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling, Mucosal Immunol, vol.6, pp.335-346, 2013. ,
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma, Nat Immunol, vol.11, pp.928-935, 2010. ,
The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma, Chest, vol.142, pp.86-93, 2012. ,
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, vol.30, pp.576-587, 2009. ,
Differential gene expression and cytokine production from neutrophils in asthma phenotypes, Eur Respir J, vol.35, pp.522-531, 2010. ,
The complex relationship between inflammation and lung function in severe asthma, Mucosal Immunol, vol.7, pp.1186-1198, 2014. ,
Antiinterleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebocontrolled trial, Lancet, vol.382, pp.1705-1713, 2013. ,
Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocytecolony-stimulating factor by human airway epithelial cells, Am J Respir Cell Mol Biol, vol.26, pp.748-753, 2002. ,
Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogenealpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis, J Immunol, vol.175, pp.404-412, 2005. ,
An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis, Immunity, vol.39, pp.676-686, 2013. ,
Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency, Blood, vol.121, pp.2385-2392, 2013. ,
Management of severe asthma in children, Lancet, vol.376, pp.814-825, 2010. ,
Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice, J Immunol, vol.181, pp.4089-4097, 2008. ,
Transcription factors GATA-3 and RORgt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma, J Immunol, vol.190, pp.1056-1065, 2013. ,
Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells, J Clin Immunol, vol.33, pp.466-478, 2013. ,
Enhanced production of IL-17A in patients with severe asthma is inhibited by 1a,25-dihydroxyvitamin D3 in a glucocorticoidindependent fashion, J Allergy Clin Immunol, vol.132, pp.297-304, 2013. ,
IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma, J Immunol, vol.185, pp.5704-5713, 2010. ,
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD41 T cells, J Clin Invest, vol.113, pp.619-627, 2004. ,
Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma, Thorax, vol.69, pp.508-515, 2014. ,
Proinflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids, J Exp Med, vol.211, pp.89-104, 2014. ,
Bronchial epithelial cells release IL-6, CXCL1 and CXCL8 upon mast cell interaction, Cytokine, vol.56, pp.823-831, 2011. ,
Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells, J Immunol, vol.179, pp.6504-6513, 2007. ,
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells, Eur Respir J, vol.39, pp.439-445, 2012. ,
Regulation and function of epithelial secreted phospholipase A2 group X in asthma, Am J Respir Crit Care Med, vol.188, pp.42-50, 2013. ,
Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients, Mucosal Immunol, vol.5, pp.140-149, 2012. ,
Th17 cytokines induce profibrotic cytokines release from human eosinophils, Respir Res, vol.14, p.34, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00802220
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-b, IL-11, IL-17, and type I and type III collagen expression, J Allergy Clin Immunol, vol.111, pp.1293-1298, 2003. ,
IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling, Inflammation, vol.36, pp.830-838, 2013. ,
Co-culture of human bronchial fibroblasts and CD41 T cells increases Th17 cytokine signature, PLoS ONE, vol.8, p.81983, 2013. ,
Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm, J Immunol, vol.183, pp.6236-6243, 2009. ,
Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop, J Biol Chem, vol.278, pp.17036-17043, 2003. ,
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype, Eur Respir Rev, vol.23, pp.118-130, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02163334
IL-17 induces type V collagen overexpression and EMT via TGFb-dependent pathways in obliterative bronchiolitis, Am J Physiol Lung Cell Mol Physiol, vol.304, pp.401-414, 2013. ,
IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-b1 to induce bronchial epithelial-mesenchymal transition (EMT), Int J Clin Exp Pathol, vol.6, pp.1481-1492, 2013. ,
Importance of epithelial mesenchymal transition (EMT) in COPD and asthma, Thorax, vol.69, p.768, 2014. ,
Th17-associated cytokines promote human airway smooth muscle cell proliferation, FASEB J, vol.26, pp.5152-5160, 2012. ,
Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention, Pharmacol Ther, vol.130, pp.325-337, 2011. ,
IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells, Am J Physiol Lung Cell Mol Physiol, vol.292, pp.1023-1029, 2007. ,
Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17-induced growth-related oncogenes, J Allergy Clin Immunol, vol.130, pp.977-985, 2012. ,
TH17 cytokines induce human airway smooth muscle cell migration, J Allergy Clin Immunol, vol.127, pp.1046-1053, 2011. ,
IL-17A produced by ab T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction, Nat Med, vol.18, pp.547-554, 2012. ,
Small G proteins in the cardiovascular system: physiological and pathological aspects, Physiol Rev, vol.93, pp.1659-1720, 2013. ,
double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma, Am J Respir Crit Care Med, vol.188, pp.1294-1302, 2013. ,
Inhibition by dexamethasone of human neutrophil apoptosis in vitro, Nat Immun, vol.14, pp.198-208, 1995. ,
Effects of steroid therapy on inflammatory cell subtypes in asthma, Thorax, vol.65, pp.384-390, 2010. ,
National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program, J Allergy Clin Immunol, vol.119, pp.405-413, 2007. ,